Toggle navigation
HU Home
عربي
Home
About me
Publications
Students
Announcements
Contact
AHMED ABDEL FATTAH AHMED SALEM
Faculty of Medicine
AHMED ABDEL FATTAH AHMED SALEM
Faculty of Medicine
عربي
Welcome
Students
Publications
Research Interests
Published Research
Published Books
Academic Conferences
Thesis Supervision
Awards/Prizes/Orders
Ongoing Research
Contact us
Welcome to the Hashemite University faculty staff website.
Ahmed Abdel Fattah Ahmed Salem
Assistant Professor
Molecular Biology of Cancer Radiation Oncology
Faculty of Medicine
Department of Anatomy, Physiology and Biochemistry
asalem@hu.edu.jo
http://www.myname.com
ORCID ID :
151487072
Office No. :
1019
EXT :
C.V. Document file as PDF:
Ph.D.
University of Manchester
United Kingdom,2017
Master
Newcastle University
United Kingdom,2013
Bachelor
Misr University for Science and Technology
Egypt,2005
Therapeutic biomarkers, tumour hypoxia, hypoxia biomarkers, pragmatic radiotherapy trials, thoracic proton radiotherapy, MR guided thoracic radiotherapy, biomarker-driven drug/ radiotherapy trials, re-irradiation, functional imaging (MRI and PET)
2023 1. Salem A. Hypoxia-Targeted Dose Painting in Radiotherapy. Semin Radiat Oncol. 2023 Jul;33(3):298-306. doi: 10.1016/j.semradonc.2023.03.009. 2. Craddock M, Nestle U, Koenig J, Schimek-Jasch T, Kremp S, Lenz S, Banfill K, Davey A, Price G, Salem A, Faivre-Finn C, van Herk M, McWilliam A. Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial. J Thorac Oncol. 2023 Jan;18(1):57-66. 2022 2. Fornacon-Wood I, Chan C, Bayman N, Banfill K, Coote J, Garbett A, Harris M, Hudson A, Kennedy K, Pemberton L, Salem A, Sheikh H, Whitehurst P, Woolf D, Price G, Faivre-Finn C. Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer. Front Oncol. 2022 May 31;12:835844. 3. Salem A, Franks K, Greystoke A, Hanna GG, Harrow S, Hatton M, Hiley C, McDonald F, Faivre-Finn C. Unaccounted Confounders Limit the Ability to Draw Conclusions From Big Data Analysis Comparing Radiotherapy Fractionation Regimens in NSCLC. J Thorac Oncol. 2022 Jun;17(6):e55- e56. 4. Van der Weijst L, Aguado-Barrera ME, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Calvo- Crespo P, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Dunning AM, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Gutiérrez-Enr?quez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Mollà M, Lambrecht M, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa-Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Lorenzo B, Talbot CJ, Valdagni R, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML; REQUITE Consortium, Lievens Y. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). Lung Cancer. 2022 Apr;166:228-241. 5. van der Weijst L, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Giandini T, Giraldo A, Gutiérrez-Enr?quez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Lambrecht M, Lang P, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Valladares B, Talbot CJ, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML, Lievens Y; REQUITE consortium. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study. Radiother Oncol. 2022 Nov;176:127-137. 6. Lane B, Khan MT, Choudhury A, Salem A, West CML. Development and validation of a hypoxia- associated signature for lung adenocarcinoma. Sci Rep. 2022 Jan 25;12(1):1290. 7. Saha A, Dickinson P, Shrimali RJ, Salem A, Agarwal A. Is thoracic radiotherapy an absolute contraindication for treatment of lung cancer patients with interstitial lung disease? A systematic review. Clin Oncol (R Coll Radiol). 2022 Feb 12;S0936-6555(22)00080-2. 8. Abravan A, Salem A, Price G, Faivre-Finn C, van Herk M. Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study. Acta Oncol. 2022 Jan 3;1-9.
2023-current MSc main supervisor Project title: Investigating nicotine metabolism and the effect of smoking on cardiovascular disease and lung cancer risk in Jordanians using genetic, epigenetic and blood biomarkers: A multi-cohort study 2022-current MSci main supervisor Project title: Post-radiotherapy oesophageal toxicity predictors: Pooled data from 2,131 lung cancer patients
3.2018-1.2022 Senior clinical lecturer (associate professor) University of Manchester, UK 5.2018-1.2022 Clinical oncology consultant (Thoracic Oncology) Christie NHS Foundation Trust, UK Pennine NHS Trust, UK 9.2014-2.2018 Clinical research fellow (Lung cancer research) University of Manchester, UK 9.2014-2.2018 Clinical oncology fellow (Lung cancer fellowship) Christie NHS Foundation Trust, UK
Genetics, biochemistry, molecular biology, endocrine module, GIT module, PNS module, GUS module, MSS module
AWARDS, ACADEMIC PRIZES, DISTINCTIONS AND SCHOLARSHIPS 2022 King Hussein Award for Cancer Research: Young investigator Regional Track 2019 University of Manchester Clinical Presidential Research Fellowship: Faculty of Biology, Medicine & Health 2018 Nominated for Outstanding contribution to Research Award (6th Annual Greater Manchester Clinical Research Awards) 2018 ESTRO-Accuray award, European Society for Radiotherapy and Oncology 37 annual meeting 2017 Finalist, Manchester medical society registrar research prize 2016 Finalist, MCCR workshop innovative protocol award 2015 Finalist, clinical oncologists’ trials sandpit RCR/ CTRad award 2013 UCL Scholarship for Exceptional Applicants 2012 University of Sheffield Jordan postgraduate scholarship Lancaster University MBA high potential scholarship Jordan oncology society conference best presentation award 2011 ASTRO International-US Annual Meeting Scientific Abstract Award, American Society for Therapeutic Radiology and Oncology 2010 Jordan oncology society conference speaker award PROFESSIONAL ADVISORY/ CONSULTANCY WORK IN LOCAL/ NATIONAL/ INTERNATIONAL ARENA Editorial board service: Scientific Reports Journal of radiotherapy in practice I have referred grant proposals, abstracts and awards for: Health Research Council of New Zealand American Association of Physicists in Medicine (AAPM) Dutch cancer society European Association for Cancer Research Swiss National Science Foundation Royal College of Radiologists, UK I have referred manuscripts for the following journals: JAMA Oncology Lung Cancer International Journal of Radiation Oncology • Biology • Physics (IJROBP) British Journal of Cancer Radiotherapy and Oncology BMC Cancer Scientific reports Radiology The Scientific Pages of Lung Cancer Molecular Diagnosis and Therapy Journal of Gastrointestinal Cancer Clinical Genitourinary Cancer Urologic oncology Journal of Radiotherapy in Practice Journal of Cancer Research and Therapeutics Journal of Cancer Metastasis and Treatment Journal of Cancer Therapy Journal of Thoracic disease Journal of Solid Tumors Advances in Cancer Research and Treatment Oman Medical Journal
ESTRO, RCR
YEAR ROLE 2021-current Director and chair Course: European Society for Radiotherapy and Oncology FALCON lung cancer re-irradiation contouring workshops 2021-current Faculty teacher "Cell survival versus dose relationships" Course: Biological Basis of Cancer Therapy teaching Radiobiology, Christie NHS Foundation Trust, UK 2020-current Director and chair Course: European Society for Radiotherapy and Oncology FALCON lung cancer and thoracic SBRT contouring workshops I led the design of a greatly improved version of these contouring with overwhelming positive user feedback
Copyright © 2018 The Hashemite University ICET.